Phoreus Biotech Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4.43M

  • Investors
  • 1

Phoreus Biotech General Information

Description

Developer of medical technology designed to increase efficacy in creating and delivering novel vaccines. The company offers customized branched amphipathic peptide capsules along with proprietary antisense oligonucleotide technology to provide stability in circulation and reduce off-target accumulation for a novel non-toxic cancer therapy, enabling the healthcare industry to increase the creation of cancer therapies and alternative antibiotics.

Contact Information

Website
www.phoreusbiotech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 22201 West Innovation Drive
  • Olathe, KS 66061
  • United States
+1 (785)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Drug Delivery
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 22201 West Innovation Drive
  • Olathe, KS 66061
  • United States
+1 (785)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Phoreus Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 13-Mar-2026 $4.43M Completed Generating Revenue
3. Seed Round 11-May-2022 Completed Generating Revenue
2. Accelerator/Incubator $550K Completed Generating Revenue
1. Angel (individual) 30-Dec-2019 $550K $550K Completed Generating Revenue
To view Phoreus Biotech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Phoreus Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phoreus Biotech Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
KU Innovation Park Accelerator/Incubator
To view Phoreus Biotech’s complete investors history, request access »

Ready to get started?

Request a free trial

Phoreus Biotech FAQs

  • When was Phoreus Biotech founded?

    Phoreus Biotech was founded in 2018.

  • Where is Phoreus Biotech headquartered?

    Phoreus Biotech is headquartered in Olathe, KS.

  • What is the size of Phoreus Biotech?

    Phoreus Biotech has 10 total employees.

  • What industry is Phoreus Biotech in?

    Phoreus Biotech’s primary industry is Drug Discovery.

  • Is Phoreus Biotech a private or public company?

    Phoreus Biotech is a Private company.

  • What is Phoreus Biotech’s current revenue?

    The current revenue for Phoreus Biotech is .

  • How much funding has Phoreus Biotech raised over time?

    Phoreus Biotech has raised $6.91M.

  • Who are Phoreus Biotech’s investors?

    KU Innovation Park has invested in Phoreus Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process